ProNoxis develops, produces, and markets novel treatments for autoimmune disorders.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Göteborg
State: Vastra Gotaland
Zip:
Country: Sweden
ProNoxis develops, produces and markets novel treatments for autoimmune disorders where modification of NADPH oxidase (NOX2) activity is one key for diseases like rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease (IBD). ProNoxis is a spin-out from Redoxis.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2009 | Venture Round | 2 | - |
Lund University Bioscience Karolinska Lund University Bioscience Karolinska |
6/2009 | Venture Round | 2 | - |
Karolinska Lund University Bioscience Karolinska Lund University Bioscience |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|